Gunasegaran B, Ashley C, Marsh-Wakefield F, Guillemin G, Heng B
BJC Rep. 2024; 2(1):33.
PMID: 39516641
PMC: 11524015.
DOI: 10.1038/s44276-024-00051-z.
Koruga N, Pekmezovic T, Tomas I, Soldo Koruga A, Marjanovic K, Rajc J
Acta Clin Croat. 2023; 61(3):476-481.
PMID: 37492371
PMC: 10364100.
DOI: 10.20471/acc.2022.61.03.12.
Ahn J, Shin C, Kim Y, Park J, Jeun S, Ahn S
Brain Tumor Res Treat. 2022; 10(3):135-143.
PMID: 35929110
PMC: 9353163.
DOI: 10.14791/btrt.2022.0010.
Daei Sorkhabi A, Sarkesh A, Saeedi H, Marofi F, Ghaebi M, Silvestris N
Front Oncol. 2022; 12:818447.
PMID: 35515137
PMC: 9062077.
DOI: 10.3389/fonc.2022.818447.
Harrison M, Hochreiner E, Benjamin B, Lawler S, Zwezdaryk K
Viruses. 2022; 14(1).
PMID: 35062307
PMC: 8777757.
DOI: 10.3390/v14010103.
Presence of the Human Cytomegalovirus in Glioblastomas-A Systematic Review.
Peredo-Harvey I, Rahbar A, Soderberg-Naucler C
Cancers (Basel). 2021; 13(20).
PMID: 34680198
PMC: 8533734.
DOI: 10.3390/cancers13205051.
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?.
Quintarelli C, Camera A, Ciccone R, Alessi I, Del Bufalo F, Carai A
Front Immunol. 2021; 12:634031.
PMID: 34163465
PMC: 8216238.
DOI: 10.3389/fimmu.2021.634031.
Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells.
Yaiw K, Mohammad A, Taher C, Cui H, Costa H, Kostopoulou O
Microorganisms. 2021; 9(6).
PMID: 34070407
PMC: 8229579.
DOI: 10.3390/microorganisms9061137.
Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens-A Novel, Automated Immunohistochemical Staining Protocol.
Touma J, Liu Y, Rahbar A, Pantalone M, Almazan N, Vetvik K
Microorganisms. 2021; 9(5).
PMID: 34068349
PMC: 8153275.
DOI: 10.3390/microorganisms9051059.
Virome assembly and annotation in brain tissue based on next-generation sequencing.
Yuan Z, Ye X, Zhu L, Zhang N, An Z, Zheng W
Cancer Med. 2020; 9(18):6776-6790.
PMID: 32738030
PMC: 7520322.
DOI: 10.1002/cam4.3325.
Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment.
Blaylock R
Surg Neurol Int. 2019; 10:199.
PMID: 31768279
PMC: 6826277.
DOI: 10.25259/SNI_361_2019.
Vaccine Vectors Harnessing the Power of Cytomegaloviruses.
Ynga-Durand M, Dekhtiarenko I, Cicin-Sain L
Vaccines (Basel). 2019; 7(4).
PMID: 31627457
PMC: 6963789.
DOI: 10.3390/vaccines7040152.
Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.
Wilski N, Del Casale C, Purwin T, Aplin A, Snyder C
J Virol. 2019; 93(20).
PMID: 31375579
PMC: 6798091.
DOI: 10.1128/JVI.00533-19.
From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer.
Wilski N, Snyder C
Vaccines (Basel). 2019; 7(3).
PMID: 31323930
PMC: 6789822.
DOI: 10.3390/vaccines7030062.
Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.
Loit M, Adle-Biassette H, Bouazza S, Mazeron M, Manivet P, Lehmann-Che J
J Neurovirol. 2018; 25(1):50-56.
PMID: 30397828
DOI: 10.1007/s13365-018-0683-8.
Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.
Deshpande R, Panigrahi M, Y B V K C, Prakash Babu P
Neurol Sci. 2018; 39(11):1895-1902.
PMID: 30090984
DOI: 10.1007/s10072-018-3518-8.
The Human Cytomegalovirus, from Oncomodulation to Oncogenesis.
Herbein G
Viruses. 2018; 10(8).
PMID: 30081496
PMC: 6115842.
DOI: 10.3390/v10080408.
Lack of cytomegalovirus detection in human glioma.
Garcia-Martinez A, Alenda C, Irles E, Ochoa E, Quintanar T, Rodriguez-Lescure A
Virol J. 2017; 14(1):216.
PMID: 29116009
PMC: 5678593.
DOI: 10.1186/s12985-017-0885-3.
Increased infiltration and tolerised antigen-specific CD8 T cells in tumor but not peripheral blood have no impact on survival of HCMV glioblastoma patients.
Bahador M, Gras Navarro A, Rahman M, Dominguez-Valentin M, Sarowar S, Ulvestad E
Oncoimmunology. 2017; 6(8):e1336272.
PMID: 28919997
PMC: 5593710.
DOI: 10.1080/2162402X.2017.1336272.
Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.
Ornaghi S, Hsieh L, Bordey A, Vergani P, Paidas M, van den Pol A
J Neurosci. 2017; 37(29):6877-6893.
PMID: 28630251
PMC: 5518418.
DOI: 10.1523/JNEUROSCI.0970-17.2017.